Creation, cannulation and survival of arteriovenous fistulae: Data from the dialysis outcomes and practice patterns study

被引:263
作者
Rayner, HC
Pisoni, RL
Gillespie, BW
Goodkin, DA
Akiba, T
Akizawa, T
Saito, A
Young, EW
Port, FK
机构
[1] Univ Renal Res & Educ Assoc, Ann Arbor, MI 48103 USA
[2] Birmingham Heartlands Hosp, Dept Renal Med, Birmingham B9 5ST, W Midlands, England
[3] Univ Michigan, Ann Arbor, MI 48109 USA
[4] Amgen Inc, Thousand Oaks, CA 91320 USA
[5] Tokyo Womens Med Univ, Tokyo, Japan
[6] Wakayama Med Univ, Wakayama, Japan
[7] Tokai Univ, Sch Med, Kanagawa 2591100, Japan
[8] Vet Adm Med Ctr, Ann Arbor, MI 48105 USA
关键词
arteriovenous fistula; vascular access; hemodialysis; end-stage renal disease; cannulation practice; fistula survival; DOPPS;
D O I
10.1046/j.1523-1755.2003.00724.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. An arteriovenous (A-V) fistula is the optimal vascular access for hemodialysis. The National Kidney Foundation Dialysis Outcomes Quality Initiative (DOQI) recommends that fistulae should mature for at least one month before cannulation, but this recommendation is not evidence-based. If fistulae are created prior to ESRD and cannulation is possible earlier without compromising fistula survival, the need for temporary catheters would be reduced. Methods. Prospective observational data were analyzed for a random sample (N = 3674) of incident patients at the time of initiating hemodialysis, hemofiltration or hemodiafiltration in 309 facilities in France, Germany, Italy, Japan, Spain, the United Kingdom, and the United States, taking part in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Results. Although the proportion of patients who had pre-dialysis care by a nephrologist differed little between countries, there were large variations in the proportion of patients who commenced hemodialysis via an A-V fistula, A-V graft or central venous catheter. The usual time interval between referral and creation of A-V fistulae also differed greatly between countries. For new hemodialysis (HD) patients initiating HD with an A-V fistula (N = 894) the following results were observed: (1 ) median time to first cannulation varied greatly between countries: Japan and Italy (25 and 27 days), Germany (42 days), Spain and France (80 and 86 days), UK and US (96 and 98 days). (2 ) No association was found between cannulation less than or equal to28 days versus>28 days for patient characteristics of age, gender, and fifteen different classes of patient co-morbid factors. (3 ) Risk of A-V fistula failure was increased for incident patients who had a prior temporary access [relative risk (RR) = 1.81, P = 0.01] or who were female (RR = 1.52, P = 0.02). (4 ) Cannulation less than or equal to14 days after creation was associated with a 2.1-fold increased risk of subsequent fistula failure (P = 0.006) compared to fistulae cannulated>14 days. (5 ) No significant difference in A-V fistula failure was seen for fistulae cannulated in 15 to 28 days compared with 43 to 84 days. Conclusion. Significant differences in clinical practice currently exist between countries regarding the creation of A-V fistulae prior to starting hemodialysis and the timing of initial cannulation. Cannulation within 14 days of creation is associated with reduced long-term fistula survival. Fistulae ideally should be left to mature for at least 14 days before first cannulation.
引用
收藏
页码:323 / 330
页数:8
相关论文
共 21 条
[1]   A multidisciplinary approach to hemodialysis access: Prospective evaluation [J].
Allon, M ;
Bailey, R ;
Ballard, R ;
Deierhoi, MH ;
Hamrick, K ;
Oser, R ;
Rhynes, VK ;
Robbin, ML ;
Saddekni, S ;
Zeigler, ST .
KIDNEY INTERNATIONAL, 1998, 53 (02) :473-479
[2]  
[Anonymous], 2001, AM J KIDNEY DIS, V37, pS137, DOI DOI 10.1016/S0272-6386(01)70007-8
[3]   Changes in the practice of angioaccess surgery: Impact of dialysis outcome and quality initiative recommendations [J].
Ascher, E ;
Gade, P ;
Hingorani, A ;
Mazzariol, F ;
Gunduz, Y ;
Fodera, M ;
Yarkovich, W .
JOURNAL OF VASCULAR SURGERY, 2000, 31 (01) :84-90
[4]   Timing of nephrologist referral and arteriovenous access use: The CHOICE study [J].
Astor, BC ;
Eustace, JA ;
Powe, NR ;
Klag, MJ ;
Sadler, JH ;
Fink, NE ;
Coresh, J .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 38 (03) :494-501
[5]   Epidemiological data of treated end-stage renal failure in the European Union (EU) during the year 1995: report of the European Renal Association Registry and the National Registries [J].
Berthoux, F ;
Jones, E ;
Gellert, R ;
Mendel, S ;
Saker, L ;
Briggs, D .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 (10) :2332-2342
[6]   CHRONIC HEMODIALYSIS USING VENIPUNCTURE AND A SURGICALLY CREATED ARTERIOVENOUS FISTULA [J].
BRESCIA, MJ ;
CIMINO, JE ;
APPEL, K ;
HURWICH, BJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1966, 275 (20) :1089-&
[7]  
Combe C, 2001, NEPHROLOGIE, V22, P379
[8]   VASCULAR ACCESS THROMBOSIS IN NEW HEMODIALYSIS-PATIENTS [J].
CULP, K ;
FLANIGAN, M ;
TAYLOR, L ;
ROTHSTEIN, M .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1995, 26 (02) :341-346
[9]   Type of vascular access and mortality in US hemodialysis patients [J].
Dhingra, RK ;
Young, EW ;
Hulbert-Shearon, TE ;
Leavey, SF ;
Port, FK .
KIDNEY INTERNATIONAL, 2001, 60 (04) :1443-1451
[10]   Outcome of primary radiocephalic fistula for haemodialysis [J].
Golledge, J ;
Smith, CJ ;
Emery, J ;
Farrington, K ;
Thompson, HH .
BRITISH JOURNAL OF SURGERY, 1999, 86 (02) :211-216